Abstract:The last decades of biological, toxicological, and pharmacological research have deeply changed the way researchers select the most appropriate 'pre-clinical model'. The absence of relevant animal models for many human diseases, as well as the inaccurate prognosis coming from 'conventional' pre-clinical models, are among the major reasons of the failures observed in clinical trials. This evidence has pushed several research groups to move more often from a classic cellular or animal modeling approach to an alternative and broader vision that includes the involvement of microfluidic-based technologies. The use of microfluidic devices offers several benefits including fast analysis times, high sensitivity and reproducibility, the ability to quantitate multiple chemical species, and the simulation of cellular response mimicking the closest human in vivo milieu. Therefore, they represent a useful way to study drug-organ interactions and related safety and toxicity, and to model organ development and various pathologies 'in a dish'. The present review will address the applicability of microfluidic-based technologies in different systems (2D and 3D). We will focus our attention on applications of microchip electrophoresis (ME) to biological and toxicological studies as well as in drug discovery and development processes. These include high-throughput single-cell gene expression profiling, simultaneous determination of antioxidants and reactive oxygen and nitrogen species, DNA analysis, and sensitive determination of neurotransmitters in biological fluids. We will discuss new data obtained by ME coupled to laser-induced fluorescence (ME-LIF) and electrochemical detection (ME-EC) regarding the production and degradation of nitric oxide, a fundamental signaling molecule regulating virtually every critical cellular function. Finally, the integration of microfluidics with recent innovative technologies-such as organoids, organ-on-chip, and 3D printing-for the design of new in vitro experimental devices will be presented with a specific attention to drug development applications. This 'composite' review highlights the potential impact of 2D and 3D microfluidic systems as a fast, inexpensive, and highly sensitive tool for high-throughput drug screening and preclinical toxicological studies.

Microfluidic Devices and 3D Printing for Synthesis and Screening of Drugs and Tissue Engineering

Developments of 3D Printing Microfluidics and Applications in Chemistry and Biology: a Review

Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation

Microfluidics for Medical Additive Manufacturing

Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates

Current Developments and Applications of Microfluidic Technology Toward Clinical Translation of Nanomedicines.

A review of the recent achievements and future trends on 3D printed microfluidic devices for bioanalytical applications

3D Printing and Nanotechnology: A Multiscale Alliance in Personalized Medicine

Emerging 3D printing technologies and methodologies for microfluidic development

3D‐Bioprinting for Precision Microtissue Engineering: Advances, Applications, and Prospects

A Review on 3D Printing Processes in Pharmaceutical Engineering and Tissue Engineering: Applications, Trends and Challenges

3D Printing Techniques and Their Applications to Organ-on-a-Chip Platforms: A Systematic Review

Microprinting of liver micro-organ for drug metabolism study.

Bridging the Gap: Integrating 3D Bioprinting and Microfluidics for Advanced Multi-Organ Models in Biomedical Research

Advances in three-dimensional rapid prototyping of microfluidic devices for biological applications

Microfluidic Applications in Drug Development: Fabrication of Drug Carriers and Drug Toxicity Screening

Advancing Tissue Culture with Light-Driven 3D-Printed Microfluidic Devices

Successes and future outlook for microfluidics-based cardiovascular drug discovery

Recent Advances on Cell Culture Platforms for In Vitro Drug Screening and Cell Therapies: From Conventional to Microfluidic Strategies

Microfluidics as a Novel Tool for Biological and Toxicological Assays in Drug Discovery Processes: Focus on Microchip Electrophoresis